MARKET

DNA

DNA

Ginkgo Bioworks Holdings Inc
NYSE
10.25
+0.68
+7.11%
After Hours: 10.19 -0.06 -0.55% 19:23 06/26 EDT
OPEN
9.35
PREV CLOSE
9.57
HIGH
10.34
LOW
9.35
VOLUME
2.53M
TURNOVER
--
52 WEEK HIGH
17.58
52 WEEK LOW
5.37
MARKET CAP
669.58M
P/E (TTM)
-1.9152
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DNA last week (0615-0619)?
Weekly Report · 4d ago
Weekly Report: what happened at DNA last week (0608-0612)?
Weekly Report · 06/15 09:34
Ginkgo Bioworks Shareholders Back Board, Governance Structure
TipRanks · 06/12 23:15
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation?
Seeking Alpha · 06/10 19:19
Weekly Report: what happened at DNA last week (0601-0605)?
Weekly Report · 06/08 09:32
Weekly Report: what happened at DNA last week (0525-0529)?
Weekly Report · 06/01 09:34
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
PR Newswire · 05/26 16:33
Weekly Report: what happened at DNA last week (0518-0522)?
Weekly Report · 05/25 09:36
More
About DNA
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering.

Webull offers Ginkgo Bioworks Holdings Inc stock information, including NYSE: DNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DNA stock methods without spending real money on the virtual paper trading platform.